Susquehanna International Group’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$392K Sell
17,384
-97,004
-85% -$2.19M ﹤0.01% 4667
2025
Q1
$3.2M Buy
+114,388
New +$3.2M ﹤0.01% 1703
2024
Q1
Sell
-1,287
Closed -$18.7K 6777
2023
Q4
$18.7K Buy
+1,287
New +$18.7K ﹤0.01% 5680
2023
Q2
Sell
-199
Closed -$15.5K 6606
2023
Q1
$15.5K Buy
+199
New +$15.5K ﹤0.01% 5657
2022
Q4
Hold
0
6895
2022
Q3
Sell
-421
Closed -$63K 7025
2022
Q2
$63K Sell
421
-4,211
-91% -$630K ﹤0.01% 5179
2022
Q1
$1.12M Sell
4,632
-334
-7% -$81K ﹤0.01% 2669
2021
Q4
$1.5M Sell
4,966
-845
-15% -$256K ﹤0.01% 2316
2021
Q3
$2.4M Buy
5,811
+3,544
+156% +$1.47M ﹤0.01% 1771
2021
Q2
$694K Buy
+2,267
New +$694K ﹤0.01% 3481
2021
Q1
Sell
-297
Closed -$59K 5852
2020
Q4
$59K Buy
297
+153
+106% +$30.4K ﹤0.01% 4599
2020
Q3
$24K Buy
144
+16
+13% +$2.67K ﹤0.01% 4294
2020
Q2
$32K Sell
128
-181
-59% -$45.3K ﹤0.01% 4085
2020
Q1
$56K Buy
309
+52
+20% +$9.42K ﹤0.01% 4185
2019
Q4
$74K Sell
257
-486
-65% -$140K ﹤0.01% 3721
2019
Q3
$203K Buy
743
+186
+33% +$50.8K ﹤0.01% 3836
2019
Q2
$209K Buy
+557
New +$209K ﹤0.01% 3863
2019
Q1
Sell
-718
Closed -$153K 4716
2018
Q4
$153K Sell
718
-211
-23% -$45K ﹤0.01% 3055
2018
Q3
$416K Sell
929
-280
-23% -$125K ﹤0.01% 2146
2018
Q2
$490K Sell
1,209
-238
-16% -$96.5K ﹤0.01% 2227
2018
Q1
$790K Buy
1,447
+1,018
+237% +$556K ﹤0.01% 1692
2017
Q4
$259K Buy
+429
New +$259K ﹤0.01% 2936
2017
Q3
Hold
0
4362
2015
Q3
Sell
-1,617
Closed -$356K 4603
2015
Q2
$356K Buy
+1,617
New +$356K ﹤0.01% 3642